Eliquis and Multiple allergies - a phase IV clinical study of FDA data

Summary:

Multiple allergies is reported as a side effect among people who take Eliquis (apixaban), especially for people who are male, 60+ old, also take Epinephrine, and have Anaphylaxis.

The phase IV clinical study analyzes which people have Multiple allergies when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,859 Eliquis users. Check the latest studies of Eliquis.

What is Multiple allergies?

Multiple allergies (allergy to multiple agents) is found to be associated with 718 drugs and 607 conditions by eHealthMe. Check the latest studies of Multiple allergies.

On Jul, 11, 2026

189,425 people reported to have side effects when taking Eliquis.
Among them, 212 people (0.11%) have Multiple allergies.

Among these 212 people:

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and have Multiple allergies?

- Check whether Multiple allergies is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eliquis:

Eliquis (191,859 reports)

Multiple allergies treatments and more:

Multiple allergies (32,053 reports)

How severe was Multiple allergies and when was it recovered:

Multiple allergies in Eliquis

Expand to all the drugs that have ingredients of apixaban:

Multiple allergies and drugs with ingredients of apixaban (290 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple allergies:

Multiple allergies (718 drugs)

Browse all the conditions that are associated with Multiple allergies:

Multiple allergies (607 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.